Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody

J Neuroimmunol. 2020 Dec 15:349:577431. doi: 10.1016/j.jneuroim.2020.577431. Epub 2020 Oct 29.

Abstract

This study aimed to determine the seasonal impact on the clinical onset of inflammatory neurological diseases of the central nervous system by analyzing the onset month with information on clinical manifestations in Japanese patients. As a result, patients with anti-aquaporin-4 antibodies (AQP4-IgG)-positive neuromyelitis optica spectrum disorders (NMOSD) showed spring-summer predominance of the clinical onset. Conversely, patients with anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease showed autumn-winter predominance of the clinical onset. Both seasonal variations were irrespective of the clinical manifestation. Environmental factors with seasonal variation influence the development of neurological conditions related to AQP4-IgG and MOG-IgG.

Keywords: Aquapotin-4; Attacks; Myelin-oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorders; Seasonal distribution.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aquaporin 4 / blood*
  • Autoantibodies / blood*
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Myelin-Oligodendrocyte Glycoprotein / blood*
  • Neuromyelitis Optica / blood*
  • Neuromyelitis Optica / diagnosis
  • Neuromyelitis Optica / epidemiology
  • Seasons*
  • Young Adult

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Autoantibodies
  • MOG protein, human
  • Myelin-Oligodendrocyte Glycoprotein